FIELD: medicine.
SUBSTANCE: invention may be used in medicine. DNA coding a peptide able to bind with TGF-β1 and to inhibit its biological activity in vitro and in vivo is used as an agent inhibiting biological activity of TGF-β1.
EFFECT: invention enables the effective treatment of diseases or pathological disorders associated with hyperexpression or dysregulated expression of TGF-β1 due to inhibition of biological activity of TGF-β1.
4 cl, 6 dwg, 4 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PEPTIDE CAPABLE OF BINDING WITH β AND INHIBITING BIOLOGICAL ACTIVITY OF β IN VITRO AND/OR IN VIVO, APPLICATION OF PEPTIDE, PHARMACEUTICAL COMPOSITION, DNA SEQUENCE, DNA STRUCTURE, EXPRESSION VECTOR, HOST-CELL AND METHOD OF OBTAINING PEPTIDE | 2004 |
|
RU2333917C2 |
| PEPTIDES HAVING CAPACITY TO BIND WITH SCURFIN AND USE THEREOF | 2008 |
|
RU2502741C2 |
| ANTI-GARP-TGF-β-ANTIBODIES | 2018 |
|
RU2767784C2 |
| INTEGRIN ανβ8 NEUTRALISING ANTIBODIES | 2011 |
|
RU2565539C2 |
| APPLICATION OF INHIBITING TGF-beta1 PEPTIDES FOR PREPARATION OF AGENT MODULATING IMMUNE RESPONSE | 2005 |
|
RU2420307C2 |
| ALPHA-V BETA-8-BINDING ANTIBODIES | 2012 |
|
RU2614252C2 |
| INHIBITORS OF SIGNAL TRANSMISSION OF TRANSFORMING GROWTH FACTORS (TGF-R) FOR TREATMENT OF CNS DISORDERS | 2005 |
|
RU2385933C2 |
| ANTIBODY OR FRAGMENT THEREOF WITH HIV-NEUTRALISING ACTIVITY | 2005 |
|
RU2380378C2 |
| CONJUGATES FOR ADMINISTERING BIOLOGICALLY ACTIVE COMPOUNDS | 2009 |
|
RU2567667C2 |
| ANTIBODIES SPECIFICALLY BOUND TO EPIDERMAL GROWTH FACTOR RECEPTORS | 2009 |
|
RU2518239C2 |
